A longitudinal cohort study of 1,440 nonagenarians demonstrates that targeted cognitive training combined with metabolic optimization can reverse age-related white matter degradation and improve executive function well into the 10th decade.
A new neuroimaging study overturns the classical “language organ” model, showing that adult speech learning relies on real-time prediction error signals between motor and auditory cortices, not innate grammatical modules.
Yale researchers identify tunneling nanotubes as the direct intercellular route for α-synuclein transfer, explaining the stereotypical spread of Parkinson’s pathology along neural circuits.
A study published in *Nature Neuroscience* identifies a previously overlooked recessive gene mutation that disrupts the endoplasmic reticulum–mitochondria axis, providing the long-sought molecular cause of a rare neurodegenerative disorder.
This review demonstrates that a popular over-the-counter brain supplement is significantly linked to increased all-cause mortality in men, driven by mechanisms involving mitochondrial stress and epigenetic dysregulation.
This paper reviews the molecular mechanisms of autophagy and presents a daily protocol combining intermittent fasting, exercise, and natural compounds to activate AMPK-mTOR pathways for longevity.
Drawing on recent clinical data from Harvard and Stanford, this paper reveals how photoperiod and gut microbiota synergistically repair deep sleep via the melatonin–short-chain fatty acid axis, and provides actionable circadian reset protocols.
Exploring health mechanisms and lifestyle strategies.
This paper reviews a recently identified brainstem-to-cortex circuit that, during slow-wave sleep, simultaneously triggers muscle protein synthesis, adipose tissue lipolysis, and glymphatic clearance of neurotoxic metabolites.
A mechanistic review of how the circadian clock gates mitochondrial autophagy via NAD+/SIRT1, and a time-restricted intervention protocol to restore slow-wave sleep.
A newly identified mechanism suggests Alzheimer's disease is triggered not by amyloid-beta accumulation, but by an age-related loss of a specific lipid-processing enzyme in microglia, initiating a cascade of neuroinflammation and tau pathology.
Exploring health mechanisms and lifestyle strategies.
A landmark study in *Nature Neuroscience* demonstrates that open-label placebo—administered with full transparency—can enhance working memory via prefrontal-hippocampal circuit activation, offering a novel non-pharmacological avenue for cognitive decline.